Astrana Health (NASDAQ:ASTH) Upgraded at Zacks Research

Zacks Research upgraded shares of Astrana Health (NASDAQ:ASTH) from a strong sell rating to a hold rating in a research note published on Monday,Zacks.com reports.

Other analysts have also recently issued reports about the stock. BTIG Research lowered their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Barclays dropped their price objective on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Finally, Needham & Company LLC started coverage on Astrana Health in a research note on Friday, December 12th. They issued a “buy” rating and a $28.00 target price on the stock. Eight equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $41.33.

Astrana Health Stock Down 5.3%

Shares of NASDAQ ASTH opened at $25.68 on Monday. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.27. The company has a market cap of $1.45 billion, a P/E ratio of 135.17, a P/E/G ratio of 0.68 and a beta of 0.87. Astrana Health has a 52 week low of $20.12 and a 52 week high of $39.97. The business has a 50-day simple moving average of $24.09 and a two-hundred day simple moving average of $26.83.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The firm had revenue of $956.05 million during the quarter, compared to analysts’ expectations of $952.83 million. During the same period in the previous year, the company posted $0.33 earnings per share. The company’s quarterly revenue was up 99.7% compared to the same quarter last year. Research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares in the last quarter. Covestor Ltd boosted its stake in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after buying an additional 2,192 shares in the last quarter. Tower Research Capital LLC TRC grew its position in Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares during the last quarter. State of Wyoming purchased a new position in shares of Astrana Health during the second quarter worth approximately $132,000. Finally, Citizens Financial Group Inc. RI purchased a new position in shares of Astrana Health during the third quarter worth approximately $204,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.